Nordhealth AS (STU:6E5) Total Long-Term Assets: €47.04 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:6E5 Nordhealth AS STU:6E5
75 GF Score
Price €2.14
GF Value €3.28
! 1 Warning Sign
View Full Analysis

What is Nordhealth AS Total Long-Term Assets?

Nordhealth AS STU:6E5 +5.94% 75 Total Long-Term Assets is €47.04 Mil as of Jun. 2026. GuruFocus rates STU:6E5 with a GF Score™ of 75/100 and a GF Value™ of €3.28. The stock has 1 warning sign investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Nordhealth AS's Total Long-Term Assets for the quarter that ended in Jun. 2026 was €47.04 Mil.


Nordhealth AS Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Nordhealth AS's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nordhealth AS Total Long-Term Assets Chart

Nordhealth AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial 49.21 70.34 63.55 55.74 49.49

Nordhealth AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.88 51.24 49.49 48.97 47.04
STU:6E5
75GF Score
Nordhealth AS STU:6E5
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nordhealth AS Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of €47.04 Mil mean?
Nordhealth AS (STU:6E5) has a Total Long-Term Assets of €47.04 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Nordhealth AS and its competitors.
Is Nordhealth AS's Total Long-Term Assets too high?
Nordhealth AS's current Total Long-Term Assets is €47.04 Mil. Overall, Nordhealth AS has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Nordhealth AS's Total Long-Term Assets compare to VEEV and BTSG?
Nordhealth AS's Total Long-Term Assets of €47.04 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Healthcare Providers & Services company?
A good Total Long-Term Assets depends on the Healthcare Providers & Services industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Nordhealth AS and its competitors. Nordhealth AS's current Total Long-Term Assets is €47.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nordhealth AS stock overvalued right now?
Nordhealth AS (STU:6E5) has a current Total Long-Term Assets of €47.04 Mil. The stock's GF Value™ is €3.28, compared to a current price of €2.14 — trading 34.8% below its estimated fair value. The current Total Long-Term Assets is €47.04 Mil. Nordhealth AS's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Nordhealth AS (STU:6E5), the current Total Long-Term Assets is €47.04 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nordhealth AS (STU:6E5) Overvalued in 2026?

Based on GuruFocus' analysis, Nordhealth AS stock appears to be undervalued. The current stock price of €2.14 is trading 34.8% below its estimated GF Value™ of €3.28.

Key valuation signals for STU:6E5:

  • Total Long-Term Assets: €47.04 Mil
  • GF Value™: €3.28 vs. price of €2.14 (34.8% below fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the STU:6E5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nordhealth AS Business Description

Other Exchanges NORDH:Norway
Address Hasleveien 28A, Oslo, NOR, 0571
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
75GF Score

Get the complete analysis for STU:6E5

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.14
Price
€3.28
GF Value